Showing results (581-590 of 739) with videos related to
Sort By:
Pageof 74
Journal of Proteomics|March 27, 2013
Towards a functional proteomics approach to the comprehension of idiopathic pulmonary fibrosis, sarcoidosis, systemic sclerosis and pulmonary Langerhans cell histiocytosisC Landi, E Bargagli, L Bianchi, et al.Journal of Robotic Surgery|May 25, 2019
Robot-assisted radical cystectomy with totally intracorporeal urinary diversion: surgical and early functional outcomes through the learning curve in a single high-volume centerA Porreca, F Mineo Bianchi, D Romagnoli, et al.Methods of Information in Medicine|November 12, 2002
Classification of EEG mental patterns by using two scalp electrodes and Mahalanobis distance-based classifiersF Cincotti, D Mattia, C Babiloni, et al.Journal of the Neurological Sciences|September 4, 1999
Zidovudine-induced experimental myopathy: dual mechanism of mitochondrial damageA Masini, C Scotti, A Calligaro, et al.Schweizerische Medizinische Wochenschrift|July 28, 1984
[Delta superinfection of hepatitis B in Switzerland: histology and serology of 28 patients]E Stöcklin, F Gudat, H P Spichtin, et al.European Radiology|May 20, 2006
Is microbubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma?R Vilana, L Bianchi, M Varela, et al.The British Journal of Dermatology|February 17, 2017
Role of the HLA-C*06 allele in clinical response to ustekinumab: evidence from real life in a large cohort of European patientsM Talamonti, M Galluzzo, J M van den Reek, et al.Journal of Proteomics|March 19, 2013
A methodological and functional proteomic approach of human follicular fluid en route for oocyte quality evaluationL Bianchi, A Gagliardi, G Campanella, et al.American Journal of Respiratory and Critical Care Medicine|July 21, 2001
Comparison of two methods for weaning patients with chronic obstructive pulmonary disease requiring mechanical ventilation for more than 15 daysM Vitacca, A Vianello, D Colombo, et al.The Journal of Dermatological Treatment|February 10, 2025
Bimekizumab for the treatment of moderate to severe psoriasis: a real-world experience over 52 weeks from two Italian dermatology clinicsE Mortato, F Artosi, C Borselli, et al.Pageof 74